1. Home
  2. PFO vs OVID Comparison

PFO vs OVID Comparison

Compare PFO & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

HOLD

Current Price

$9.56

Market Cap

123.3M

Sector

Finance

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

118.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFO
OVID
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
118.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
PFO
OVID
Price
$9.56
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.50
AVG Volume (30 Days)
31.8K
1.6M
Earning Date
01-01-0001
11-12-2025
Dividend Yield
6.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,610,000.00
Revenue This Year
N/A
$1,077.56
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
945.89
52 Week Low
$6.90
$0.24
52 Week High
$8.51
$2.01

Technical Indicators

Market Signals
Indicator
PFO
OVID
Relative Strength Index (RSI) 62.84 50.28
Support Level $9.43 $1.57
Resistance Level $9.51 $1.87
Average True Range (ATR) 0.07 0.10
MACD 0.02 -0.01
Stochastic Oscillator 95.24 24.19

Price Performance

Historical Comparison
PFO
OVID

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: